Chesterfield vs Crewe

.ltv-mc-ssr{position:static!important;width:auto!important;height:auto!important;padding:16px!important;margin:0!important;overflow:visible!important;clip:auto!important;clip-path:none!important;white-space:normal!important;border:initial!important;color:inherit;font-size:14px;line-height:1.5;box-sizing:border-box}.ltv-mc-ssr .ltv-mc-ssr-title{font-size:1.5em;margin:0 0 8px;font-weight:600;line-height:1.25}.ltv-mc-ssr .ltv-mc-ssr-meta{margin:0 0 16px;opacity:.85}.ltv-mc-ssr h3{font-size:1.05em;margin:18px 0 8px;font-weight:600}.ltv-mc-ssr ul,.ltv-mc-ssr ol{margin:0 0 16px;padding-left:20px}.ltv-mc-ssr li{margin:4px 0}.ltv-mc-ssr a{color:inherit;text-decoration:underline}.ltv-mc-ssr time{opacity:.7;font-variant-numeric:tabular-nums}.ltv-mc-ssr .ltv-mc-ssr-score{font-size:1.1em;margin:12px 0}.ltv-mc-ssr .ltv-mc-ssr-stats{margin:0 0 16px}

League Two · Oct 24, 2026 · 14:00

Match preview

League Two action heats up on October 24, 2026, as Chesterfield host Crewe in a fixture with intriguing narratives. The Spireites enter with a balanced record from their opening two games, securing a win and a loss, scoring two and conceding two, indicating a team finding its rhythm. Their 50% win rate suggests they possess the capability to perform, particularly at home.

Crewe, however, arrive with a point to prove after a single defeat in their only league outing so far, scoring once and conceding twice. Their 0% win rate paints a stark picture, and they will be desperate to kickstart their campaign. Recent head-to-head encounters have been a mixed bag, featuring high-scoring draws and emphatic wins for both sides, with Crewe notably delivering a 7-1 thrashing in the past, though Chesterfield also recorded a 5-0 away victory. This unpredictability adds spice to the clash. With the win probability evenly split (35% home, 35% draw, 30% away), expect a tightly contested affair. Chesterfield will aim to leverage home advantage, while Crewe will be fighting to break their early season duck. The midfield battle and clinical finishing will be key determinants.